Karin Williams

University of Glasgow — United Kingdom

Medicine · Health Sciences

31h-index3.2kcitations92works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(26), Estrogen and related hormone effects(15), Cancer-related Molecular Pathways(14), Cancer Cells and Metastasis(12), Hormonal and reproductive studies(10)

Publications92 total

In vitro assessment of benzothiadiazole-based photoactive polymers against ovarian, prostate and bladder cancer cell lines for photodynamic therapy
Discover Oncology·2025· 1 citedOpen Access
International evaluations of thoraco-abdominal normothermic regional perfusion protocols according to neurophysiological and cardiovascular implications
Brain & Heart·2025Open Access
P02.24.A MOLECULAR AND MORPHOLOGICAL FEATURES OF BLOOD VESSELS IN TUMOUR MARGIN REGIONS OF GLIOBLASTOMA ARE DISTINCT FROM TUMOUR CORE AND NORMAL BRAIN, AND DRUG DELIVERY IS REDUCED
Neuro-Oncology·2025Open Access
Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signaling
2025Open Access
Plasma <i>AR</i> Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
JAMA Oncology·2025· 3 citedOpen Access
1309: Reducing inflammatory and cognitive effects of irradiation in healthy brain using PARP inhibitors
Radiotherapy and Oncology·2024
2345: Modification of the adverse effects of radiotherapy on normal brain with the ATM inhibitor AZD1390
Radiotherapy and Oncology·2024
Abstract 7593: Photodynamic therapy improves therapeutic management of glioblastoma
Cancer Research·2024· 1 citedOpen Access
Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial
International Journal of Radiation Oncology*Biology*Physics·2024· 21 citedOpen Access
Supplementary Data from Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity
2023Open Access
Supplementary Data from Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity
2023Open Access
Supplementary Data from Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity
2023Open Access
Data from Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity
2023Open Access
Data from Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity
2023· 1 citedOpen Access
Supplementary Data from Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity
2023Open Access
Supplementary Figure 1 from Tissue-Specific Consequences of Cyclin D1 Overexpression in Prostate Cancer Progression
2023Open Access
Supplementary Figure Legends A and B from Transforming Growth Factor-β Promotes Invasion in Tumorigenic but not in Nontumorigenic Human Prostatic Epithelial Cells
2023Open Access
Supplementary Figure 2 from Tissue-Specific Consequences of Cyclin D1 Overexpression in Prostate Cancer Progression
2023Open Access
Supplementary Information and Figures 1-7 from Transforming Growth Factor-β Promotes Invasion in Tumorigenic but not in Nontumorigenic Human Prostatic Epithelial Cells
2023Open Access
Supplementary Figure 4 from Tissue-Specific Consequences of Cyclin D1 Overexpression in Prostate Cancer Progression
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Philippa T. K. Saunders(12), Simon W. Hayward(11), Chris McKinnell(8), Jane S. Fisher(8), Richard M. Sharpe(8), Omar E. Franco(7), Siegfried Kasper(7), Katie J. Turner(7), Michael Millar(6), Nina Atanassova(6), Premkumar Vummidi Giridhar(4), Anthony J. Chalmers(4), Neil A. Bhowmick(4), Marion Walker(3), Sarah E. MacPherson(3), Jiaoti Huang(3), Siam Oottamasathien(3), John C. Thomas(3), Romano T. DeMarco(3), John W. Brock(3)